Magnetotactic Bacteria AMB-1 with Active Deep Tumor Penetrability for NIR-II Photothermal Tumor Therapy

Guoming Huang,Guifen Zhu,Ruipeng Lin,Wenwen Chen,Rong Chen,Yutong Sun,Liqun Chen,Dengke Hong,Lihong Chen
DOI: https://doi.org/10.1021/acsomega.4c02914
IF: 4.1
2024-06-03
ACS Omega
Abstract:The complex tumor structure and microenvironment such as abnormal tumor vasculature, dense tumor matrix, and elevated interstitial fluid pressure greatly hinder the penetration and retention of therapeutic agents in solid tumors. The development of an advanced method for robust penetration and retention of therapeutic agents in tumors is of great significance for efficient tumor treatments. In this work, we demonstrated that magnetotactic bacteria AMB-1 with hypoxic metabolism characteristics...
chemistry, multidisciplinary
What problem does this paper attempt to address?
The paper primarily explores the application of magnetic magnetotactic bacteria AMB-1 in near-infrared II region (NIR-II) photothermal tumor therapy. The core issue of the research is how to overcome the challenges of therapeutic agent penetration and retention in solid tumors to achieve efficient tumor treatment. Specifically, the research team found that magnetic magnetotactic bacteria AMB-1 have the following characteristics: 1. **Tumor Penetration Ability**: AMB-1 can actively penetrate tumors and selectively colonize hypoxic regions within the tumor, making AMB-1 a promising intelligent drug carrier. 2. **Intrinsic NIR-II Photothermal Performance**: AMB-1 itself has the ability to efficiently convert 1064nm laser into thermal energy, which can be used for photothermal ablation of tumors. Through in vitro cell experiments and in vivo animal model experiments, researchers verified that under NIR-II laser irradiation, AMB-1 can effectively inhibit tumor cell proliferation and induce cell apoptosis. Additionally, the study also demonstrated that AMB-1 has good biosafety and does not cause significant damage to vital organs during treatment. In summary, this paper aims to develop a novel bacteria-based photothermal therapeutic agent and provides valuable insights for the advancement of advanced tumor microbial therapies.